Inspire Medical (INSP) Systems announced that its CFO, Rick Buchholz, will be stepping down from his current position with the Company, effective December 31, in order to pursue other professional opportunities. Buchholz will remain employed with the Company in a financial advisory role through February 28, 2026, to ensure a smooth transition. The Company has an active search to identify its next CFO. The Company is reaffirming its previously issued guidance for FY25 with revenue guidance of $900M-$910M, gross margin guidance of 84% to 86% and diluted net income per share guidance of 40c-50c.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on INSP:
- Inspire Medical price target lowered to $97 from $116 at Leerink
- Inspire Medical Systems Announces $200M Share Buyback
- Inspire Medical board authorizes up to $200M share repurchase program
- Inspire Medical Systems Stock (INSP) Dives After Reporting a Q2 Beat & Guidance Cut
- Inspire Medical’s Mixed Earnings Call: Growth Amid Challenges